Venture capital Archives

Pfizer Flagship alliance: a new era in pharma partnership models?

In Depth 24 Sep 2024

New partnership model on the rise: how VCs are helping Pharma hunt for their next blockbuster

Discover how the recent Pfizer-Flagship alliance model sets a trend in pharma-VC partnerships, fostering innovation in drug development.

September 24, 2024 - 9 minutesmins - By Monica Karpinski

Expert Advice 5 Jul 2024

The ABC of biotech startup funding

Funding a biotech startup can be challenging. Delve into our guide to navigate this complicated investment landscape.

July 5, 2024 - 21 minutesmins - By Jules Adam

In Depth 26 Jun 2024

Biotech megadeals: Exploring the surge in $100M+ deals

Biotech and healtcare contributed to more than one out of three megadeals in 2024, find out the reasons behind it.

June 26, 2024 - 9 minutesmins - By Jules Adam

Best in Biotech 23 May 2024

10 notable pharma and biotech venture capital arms

Discover 10 big pharma and biotech companies that have spun out their own venture capital arms to invest in startups in the industry.

May 23, 2024 - 10 minutesmins - By Willow Shah-Neville

alchemyrefiner alchemymagic 3 04e4a427 d1fa 4258 9dab 2690330368fd 0

Podcast 19 Apr 2024

The biotech investment landscape in 2024

Dive into 2024’s biotech investment strategies with RTW Investments on our podcast. Discover trends shaping the landscape ahead.”

April 19, 2024

In Depth 28 Feb 2024

Beyond fundraising: how do venture capitals build early-stage biotechs?

Venture capitals can help build early-stage biotech startups and boost innovation in the life science industry.

February 28, 2024 - 6 minutesmins - By Roohi Mariam Peter

News and Trends 8 Jan 2024

Is the biotech industry poised for recovery in 2024?

The past few years have been challenging for the industry but 2024 might be the year marking the biotech recovery.

January 8, 2024 - 5 minutesmins - By Jules Adam

News and Trends 17 Nov 2023

With $700 million Q3 rise, U.K. biotech spearheads European recovery

The U.K.’s biotechnology landscape has witnessed an impressive surge in funding, clocking a robust £563 million ($700 million) in venture capital and public financings in the third quarter of 2023, according to Biotech Finance. This achievement marks a staggering 48% increase from the previous quarter and sets a formidable pace that is already on track […]

November 17, 2023 - 4 minutesmins - By Jules Adam

In Depth 16 Nov 2023

Meet the ‘biotech mafia’: how specialized biotech VC firms are dominating industry funding once again

Between 2020 and 2022 – largely due to the biotech innovations that came about by the COVID-19 pandemic – there was an influx of generalist investors in the biotech industry, betting big on new technologies like mRNA vaccines. But, now, these investors appear to have backed off, leaving room for specialized biotech venture capital (VC) […]

November 16, 2023 - 6 minutesmins - By Willow Shah-Neville

In Depth 2 Oct 2023

PIPEs in biotech fundraising: is this growing trend fueled by economic uncertainty here to stay?

This past year has not been very sympathetic to fundraisers in the biotech industry. As the economic downturn grinds on, many companies are in need of funds to stay afloat. A recent trend in the way biotechs have secured funding, might be telling of how these companies are determined to pull through. A private investment […]

October 2, 2023 - 7 minutesmins - By Roohi Mariam Peter

In Depth 11 Sep 2023

Evolving biotech funding trends: VCs lead new series B deals, but early-stage deals require insider support

With biotech funding trends always evolving, HSBC Innovation Banking’s inaugural Venture Healthcare Report lays out the trends seen in the first half (1H) of 2023, where valuations underwent a necessary reset, and venture capitalists emerged from their cautious stance, eventually embarking on a fresh wave of investments. However, an overall decline in investment was still […]

September 11, 2023 - 5 minutesmins - By Willow Shah-Neville

News and Trends 14 Jul 2023

BioGeneration Ventures closes BGV Fund V at €150M

BioGeneration Ventures (BGV), an early-stage venture capital company in European biopharma, has closed its BGV V fund at €150 million ($167.9 million), its largest fund since launching its first fund in 2006. BGV V was oversubscribed, with demand from both existing and new investors, with existing investors Eli Lilly and Company, Novo Holdings and Bristol […]

July 14, 2023 - 2 minutesmins - By Jim Cornall

Resources

Categories

The biggest private biotech investments in August 2024

Long non-coding RNAs: what’s behind the growing “dark genome” buzz?

Approaches

Therapeutic areas

Grab your free report on 3D organoids and explore their future potential

Six biotech companies that could revolutionize obesity treatments

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us